AMANDA BRATTON ANP
Prescription History 1093127607
Nurse Practitioner in Shelbyville, IN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for AMANDA BRATTON ANP, an active Nurse Practitioner specialist practicing in Shelbyville, IN. Our medical registry currently tracks 27 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 863 documented patient claims. Among these therapy options, the most frequently utilized medication is Ozempic, which accounts for 84 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other IN PrescribersVs. IN Avg |
|---|---|---|---|
| OzempicSemaglutide | 84 | $1,698.18 | ▲ More than typical |
About Ozempic: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. In 2023, this provider wrote 84 Medicare prescriptions for Ozempic, about 2.2 times the volume of the typical Indiana prescriber of this medication (39). Medicare paid an average of $1,698.18 per fill, versus $1,432.50 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 145.1 30-Day Fills standardized to 30-day supplies 4,272 Days of Medication total across all patients in 2023 | |||
| MounjaroTirzepatide | 83 | $1,450.10 | ▲ More than typical |
About Mounjaro: Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes. A glucose-dependent insulinotropic polypeptide (GIP) receptor and Glucose-like peptide-1 (GLP-1) receptor agonist to enhance glycemic control in adults with TYPE 2 DIABETES MELLITUS. In 2023, this provider wrote 83 Medicare prescriptions for Mounjaro, about 4.4 times the volume of the typical Indiana prescriber of this medication (19). Medicare paid an average of $1,450.10 per fill, versus $1,183.51 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 106.3 30-Day Fills standardized to 30-day supplies 3,064 Days of Medication total across all patients in 2023 | |||
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 57 | $885.28 | ▲ More than typical |
About Lantus Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 57 Medicare prescriptions for Lantus Solostar, about 1.4 times the volume of the typical Indiana prescriber of this medication (42). Medicare paid an average of $885.28 per fill, versus $706.78 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 137.5 30-Day Fills standardized to 30-day supplies 4,124 Days of Medication total across all patients in 2023 | |||
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 53 | $96.65 | ▲ More than typical |
In 2023, this provider wrote 53 Medicare prescriptions for Nano 2nd Gen Pen Needle, about 2 times the volume of the typical Indiana prescriber of this medication (27). Medicare paid an average of $96.65 per fill, versus $94.75 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 110.4 30-Day Fills standardized to 30-day supplies 3,242 Days of Medication total across all patients in 2023 | |||
| TrulicityDulaglutide | 51 | $1,756.14 | ≈ Typical |
About Trulicity: Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment. In 2023, this provider wrote 51 Medicare prescriptions for Trulicity, about 1.2 times the volume of the typical Indiana prescriber of this medication (44). Medicare paid an average of $1,756.14 per fill, versus $1,381.91 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 81 30-Day Fills standardized to 30-day supplies 2,364 Days of Medication total across all patients in 2023 | |||
| Atorvastatin Calcium | 45 | $9.04▼ below IN avg | ▼ Less than typical |
About Atorvastatin Calcium: Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. In 2023, this provider wrote 45 Medicare prescriptions for Atorvastatin Calcium, about a quarter of the volume of the typical Indiana prescriber of this medication (216). Medicare paid an average of $9.04 per fill, versus $11.73 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 106 30-Day Fills standardized to 30-day supplies 3,180 Days of Medication total across all patients in 2023 | |||
| Pioglitazone Hcl | 43 | $14.37▼ below IN avg | ≈ Typical |
About Pioglitazone Hcl: Pioglitazone is a diabetes drug (thiazolidinedione-type, also called glitazones) used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes. Show more ▾ It works by helping to restore your body's proper response to insulin, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Pioglitazone is used either alone or in combination with other diabetes medications (such as metformin or a sulfonylurea such as glyburide). Talk to your doctor about the risks and benefits of pioglitazone. In 2023, this provider wrote 43 Medicare prescriptions for Pioglitazone Hcl, about 1.2 times the volume of the typical Indiana prescriber of this medication (35). Medicare paid an average of $14.37 per fill, versus $18.28 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 67 30-Day Fills standardized to 30-day supplies 1,994 Days of Medication total across all patients in 2023 | |||
| Metformin Hcl ErMetformin Hcl | 42 | $20.00 | ▼ Less than typical |
About Metformin Hcl Er: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2023, this provider wrote 42 Medicare prescriptions for Metformin Hcl Er, about 72% of the volume of the typical Indiana prescriber of this medication (58). Medicare paid an average of $20.00 per fill, versus $10.14 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 117 30-Day Fills standardized to 30-day supplies 3,496 Days of Medication total across all patients in 2023 | |||
| Glimepiride | 37 | $10.71▼ below IN avg | ▼ Less than typical |
About Glimepiride: Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. Alkaloids derived from TYRAMINE combined with 3,4-dihydroxybenzaldehyde via a norbelladine pathway, including GALANTAMINE, lycorine and crinine. They are found in the AMARYLLIDACEAE plant family. In 2023, this provider wrote 37 Medicare prescriptions for Glimepiride, about 71% of the volume of the typical Indiana prescriber of this medication (52). Medicare paid an average of $10.71 per fill, versus $10.74 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 101 30-Day Fills standardized to 30-day supplies 3,030 Days of Medication total across all patients in 2023 | |||
| JardianceEmpagliflozin | 37 | $1,465.39 | ≈ Typical |
About Jardiance: Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Empagliflozin works by increasing the removal of sodium by your kidneys. In 2023, this provider wrote 37 Medicare prescriptions for Jardiance, about 84% of the volume of the typical Indiana prescriber of this medication (44). Medicare paid an average of $1,465.39 per fill, versus $1,037.17 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 86 30-Day Fills standardized to 30-day supplies 2,580 Days of Medication total across all patients in 2023 | |||
| Levothyroxine Sodium | 31 | $12.11▼ below IN avg | ▼ Less than typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 31 Medicare prescriptions for Levothyroxine Sodium, about 19% of the volume of the typical Indiana prescriber of this medication (164). Medicare paid an average of $12.11 per fill, versus $16.04 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 85 30-Day Fills standardized to 30-day supplies 2,550 Days of Medication total across all patients in 2023 | |||
| Novolog FlexpenInsulin Aspart | 30 | $2,254.80 | ≈ Typical |
About Novolog Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 30 Medicare prescriptions for Novolog Flexpen, about 86% of the volume of the typical Indiana prescriber of this medication (35). Medicare paid an average of $2,254.80 per fill, versus $1,053.00 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 63.2 30-Day Fills standardized to 30-day supplies 1,873 Days of Medication total across all patients in 2023 | |||
| FarxigaDapagliflozin Propanediol | 29 | $1,082.52 | ≈ Typical |
About Farxiga: Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used in people with type 2 diabetes and heart disease to lower the risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sugar by your kidneys. Dapagliflozin is also used to treat kidney disease and heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sodium by your kidneys. In 2023, this provider wrote 29 Medicare prescriptions for Farxiga, about 85% of the volume of the typical Indiana prescriber of this medication (34). Medicare paid an average of $1,082.52 per fill, versus $938.67 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 51 30-Day Fills standardized to 30-day supplies 1,530 Days of Medication total across all patients in 2023 | |||
| SynthroidLevothyroxine Sodium | 28 | $71.30 | ▼ Less than typical |
About Synthroid: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 28 Medicare prescriptions for Synthroid, about 65% of the volume of the typical Indiana prescriber of this medication (43). Medicare paid an average of $71.30 per fill, versus $63.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45.8 30-Day Fills standardized to 30-day supplies 1,374 Days of Medication total across all patients in 2023 | |||
| Humalog Kwikpen U-100Insulin Lispro | 25 | $2,157.45 | ≈ Typical |
About Humalog Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 25 Medicare prescriptions for Humalog Kwikpen U-100, about 81% of the volume of the typical Indiana prescriber of this medication (31). Medicare paid an average of $2,157.45 per fill, versus $1,115.77 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 71.2 30-Day Fills standardized to 30-day supplies 2,130 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 24 | $33.95 | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 24 Medicare prescriptions for Gabapentin, about a quarter of the volume of the typical Indiana prescriber of this medication (107). Medicare paid an average of $33.95 per fill, versus $20.83 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 56 30-Day Fills standardized to 30-day supplies 1,680 Days of Medication total across all patients in 2023 | |||
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 23 | $533.42 | ≈ Typical |
About Basaglar Kwikpen U-100: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 23 Medicare prescriptions for Basaglar Kwikpen U-100, about 85% of the volume of the typical Indiana prescriber of this medication (27). Medicare paid an average of $533.42 per fill, versus $444.62 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36.1 30-Day Fills standardized to 30-day supplies 1,050 Days of Medication total across all patients in 2023 | |||
| Metformin Hcl | 22 | $13.44 | ▼ Less than typical |
About Metformin Hcl: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2023, this provider wrote 22 Medicare prescriptions for Metformin Hcl, about a quarter of the volume of the typical Indiana prescriber of this medication (101). Medicare paid an average of $13.44 per fill, versus $7.70 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 66.7 30-Day Fills standardized to 30-day supplies 2,000 Days of Medication total across all patients in 2023 | |||
| Glipizide | 18 | $10.45 | ▼ Less than typical |
About Glipizide: Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. In 2023, this provider wrote 18 Medicare prescriptions for Glipizide, about half the volume of the typical Indiana prescriber of this medication (34). Medicare paid an average of $10.45 per fill, versus $8.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 52.7 30-Day Fills standardized to 30-day supplies 1,560 Days of Medication total across all patients in 2023 | |||
| Insulin Lispro Kwikpen U-100Insulin Lispro | 16 | $706.13 | ▼ Less than typical |
About Insulin Lispro Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 16 Medicare prescriptions for Insulin Lispro Kwikpen U-100, about half the volume of the typical Indiana prescriber of this medication (29). Medicare paid an average of $706.13 per fill, versus $209.96 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39.8 30-Day Fills standardized to 30-day supplies 1,169 Days of Medication total across all patients in 2023 | |||
| Levemir FlexpenInsulin Detemir | 15 | $1,206.91 | – No State Data |
About Levemir Flexpen: Insulin detemir is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin detemir is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin detemir may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs (such as metformin, exenatide). A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS. In 2023, this provider wrote 15 Medicare prescriptions for Levemir Flexpen. Medicare paid an average of $1,206.91 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $1,206.91 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38 30-Day Fills standardized to 30-day supplies 1,129 Days of Medication total across all patients in 2023 | |||
| Humulin R U-500 KwikpenInsulin Regular, Human | 13 | $3,298.63 | ▼ Less than typical |
About Humulin R U-500 Kwikpen: Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin). In 2023, this provider wrote 13 Medicare prescriptions for Humulin R U-500 Kwikpen, about half the volume of the typical Indiana prescriber of this medication (30). Medicare paid an average of $3,298.63 per fill, versus $2,323.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19.5 30-Day Fills standardized to 30-day supplies 554 Days of Medication total across all patients in 2023 | |||
| TradjentaLinagliptin | 12 | $1,082.06 | ▼ Less than typical |
About Tradjenta: Linagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used by people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Linagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS. In 2023, this provider wrote 12 Medicare prescriptions for Tradjenta, about a third of the volume of the typical Indiana prescriber of this medication (39). Medicare paid an average of $1,082.06 per fill, versus $585.39 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 690 Days of Medication total across all patients in 2023 | |||
| Lyumjev Kwikpen U-100Insulin Lispro-Aabc | 12 | $719.64▼ below IN avg | ▼ Less than typical |
About Lyumjev Kwikpen U-100: Insulin lispro-aabc is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro-aabc is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro-aabc starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro-aabc may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). In 2023, this provider wrote 12 Medicare prescriptions for Lyumjev Kwikpen U-100, about 71% of the volume of the typical Indiana prescriber of this medication (17). Medicare paid an average of $719.64 per fill, versus $1,071.02 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 18 30-Day Fills standardized to 30-day supplies 484 Days of Medication total across all patients in 2023 | |||
| Lisinopril | 11 | $4.34▼ below IN avg | ▼ Less than typical |
About Lisinopril: Lisinopril is used to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily. One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure. In 2023, this provider wrote 11 Medicare prescriptions for Lisinopril, about 8% of the volume of the typical Indiana prescriber of this medication (131). Medicare paid an average of $4.34 per fill, versus $6.41 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 27 30-Day Fills standardized to 30-day supplies 810 Days of Medication total across all patients in 2023 | |||
| Novolin R FlexpenInsulin Regular, Human | 11 | $942.06 | ▼ Less than typical |
About Novolin R Flexpen: Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin). In 2023, this provider wrote 11 Medicare prescriptions for Novolin R Flexpen, about 73% of the volume of the typical Indiana prescriber of this medication (15). Medicare paid an average of $942.06 per fill, versus $429.83 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12.4 30-Day Fills standardized to 30-day supplies 372 Days of Medication total across all patients in 2023 | |||
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 11 | $130.14 | ▼ Less than typical |
In 2023, this provider wrote 11 Medicare prescriptions for Ultra-Fine Mini Pen Needle, about half the volume of the typical Indiana prescriber of this medication (22). Medicare paid an average of $130.14 per fill, versus $88.89 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28 30-Day Fills standardized to 30-day supplies 835 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for AMANDA BRATTON ANP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Nurse Practitioner prescribing approach at this Shelbyville, IN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among IN prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
